Researcher.Life Logo

Prostate Cancer and Prostatic Diseases : Impact Factor & More

eISSN: 1476-5608pISSN: 1365-7852

Key Metrics

CiteScore
7.8
H-Index
74
Impact Factor
< 5
SJR
Q1Urology
SNIP
1.72
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Prostate Cancer and Prostatic Diseases

Prostate Cancer and Prostatic Diseases Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGERNATURE
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year1997
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Prostate Cancer and Prostatic Diseases ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Prostate Cancer and Prostatic Diseases

Efficacy of the new P100 extracorporeal shock wave therapy device in the treatment of type IIIB chronic prostatitis/chronic pelvic pain syndrome: a sham treatment controlled, prospective clinical trial.
  • 28 Jan 2026
  • Prostate cancer and prostatic diseases
The value of micro-ultrasound for prostate cancer screening: A retrospective real-world feasibility study
  • 26 Jan 2026
  • Prostate Cancer and Prostatic Diseases
Risk of bone fractures in patients with prostate cancer treated with maximal androgen blockade therapy: a systematic literature review and meta-analysis.
  • 26 Jan 2026
  • Prostate cancer and prostatic diseases
5 T versus 3 T MRI for prostate cancer: an intra-individual prospective comparison of image quality and diagnostic performance
  • 20 Jan 2026
  • Prostate Cancer and Prostatic Diseases
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study.
  • 8 Jan 2026
  • Prostate cancer and prostatic diseases
Validation of the Prostatype® P-score for predicting prostate cancer specific mortality in a multiethnic U.S. veterans cohort.
  • 7 Jan 2026
  • Prostate cancer and prostatic diseases
Efficacy of the new P100 extracorporeal shock wave therapy device in the treatment of type IIIB chronic prostatitis/chronic pelvic pain syndrome: a sham treatment controlled, prospective clinical trial.
  • 28 Jan 2026
  • Prostate cancer and prostatic diseases
The value of micro-ultrasound for prostate cancer screening: A retrospective real-world feasibility study
  • 26 Jan 2026
  • Prostate Cancer and Prostatic Diseases
Risk of bone fractures in patients with prostate cancer treated with maximal androgen blockade therapy: a systematic literature review and meta-analysis.
  • 26 Jan 2026
  • Prostate cancer and prostatic diseases
5 T versus 3 T MRI for prostate cancer: an intra-individual prospective comparison of image quality and diagnostic performance
  • 20 Jan 2026
  • Prostate Cancer and Prostatic Diseases
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study.
  • 8 Jan 2026
  • Prostate cancer and prostatic diseases
Validation of the Prostatype® P-score for predicting prostate cancer specific mortality in a multiethnic U.S. veterans cohort.
  • 7 Jan 2026
  • Prostate cancer and prostatic diseases

FAQs on Prostate Cancer and Prostatic Diseases